The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(morpholinomethyl)-N-((S)-1-(4-((1S,2S)-2-(pyridin-3-yl)cyclopropanecarboxamido)phenyl)ethyl)benzamide ID: ALA4212358
PubChem CID: 145964830
Max Phase: Preclinical
Molecular Formula: C29H32N4O3
Molecular Weight: 484.60
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C[C@H](NC(=O)c1ccc(CN2CCOCC2)cc1)c1ccc(NC(=O)[C@H]2C[C@@H]2c2cccnc2)cc1
Standard InChI: InChI=1S/C29H32N4O3/c1-20(31-28(34)23-6-4-21(5-7-23)19-33-13-15-36-16-14-33)22-8-10-25(11-9-22)32-29(35)27-17-26(27)24-3-2-12-30-18-24/h2-12,18,20,26-27H,13-17,19H2,1H3,(H,31,34)(H,32,35)/t20-,26+,27-/m0/s1
Standard InChI Key: AWXZUTOSDKWFDE-BAURHKQJSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
1.3012 -22.4032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3001 -23.2312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0161 -23.6422 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7335 -23.2307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7307 -22.3996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0142 -21.9880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8758 -21.9767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5928 -22.3888 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8727 -21.1511 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3068 -21.9713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0158 -22.3852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7293 -21.9683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7267 -21.1420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0045 -20.7340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2981 -21.1491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4401 -20.7276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1577 -21.1346 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4438 -21.9835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1618 -22.3943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1585 -21.5670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1571 -23.2122 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
3.4393 -21.1586 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
8.4359 -19.9061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8660 -20.7186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5805 -21.1239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8597 -19.8971 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.5828 -21.9438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2964 -22.3490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0057 -21.9329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9967 -21.1072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2825 -20.7057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7207 -22.3373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7280 -23.1586 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0167 -23.5707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0221 -24.3885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7353 -24.7968 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4448 -24.3810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4411 -23.5569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 18 1 0
19 7 1 0
7 8 1 0
7 9 2 0
8 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
13 16 1 0
16 17 1 0
19 18 1 0
19 20 1 0
18 20 1 0
19 21 1 1
18 22 1 6
16 23 1 6
17 24 1 0
24 25 1 0
24 26 2 0
25 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 25 1 0
29 32 1 0
32 33 1 0
33 34 1 0
33 38 1 0
34 35 1 0
35 36 1 0
36 37 1 0
37 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 484.60Molecular Weight (Monoisotopic): 484.2474AlogP: 4.15#Rotatable Bonds: 8Polar Surface Area: 83.56Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.96CX Basic pKa: 6.66CX LogP: 3.13CX LogD: 3.06Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.50Np Likeness Score: -1.59
References 1. Palacios DS, Meredith E, Kawanami T, Adams C, Chen X, Darsigny V, Geno E, Palermo M, Baird D, Boynton G, Busby SA, George EL, Guy C, Hewett J, Tierney L, Thigale S, Weihofen W, Wang L, White N, Yin M, Argikar UA.. (2018) Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screen., 28 (3): [PMID:29275937 ] [10.1016/j.bmcl.2017.12.037 ]